Improving the arthritis component of the SLEDAI-2K
Khaled Mahmoud(University of Leeds), Edward M Vital(University of Leeds), David D’Cruz(St Thomas' Hospital), David Isenberg(Regenerative Medicine Institute), Md Yuzaiful Md Yusof(University of Leeds), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Coziana Ciurtin(University College Hospital), Chee‐Seng Yee(Unknown), Philip G. Conaghan(University of Leeds), Shah H.M. Khan(University of Lancashire), E. Hensor(University of Leeds), Lee Suan Teh(Royal Blackburn Teaching Hospital), Paul Emery(University of Leeds)
Cited by 2
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
|Annals of the Rheumatic Diseases|2013|1.4k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k